Your browser doesn't support javascript.
loading
Targeting HIF-2α as therapy for advanced cancers.
Murugesan, Thanabal; Rajajeyabalachandran, Gurukumari; Kumar, Swetha; Nagaraju, Shruthi; Jegatheesan, Sooriya Kumar.
Affiliation
  • Murugesan T; Jubilant Biosys Limited, #96, Industrial Suburb 2nd Stage, Yeshwanthpur, Bengaluru 560022, Karnataka, India. Electronic address: Thanabal.M@jubilantbiosys.com.
  • Rajajeyabalachandran G; Jubilant Biosys Limited, #96, Industrial Suburb 2nd Stage, Yeshwanthpur, Bengaluru 560022, Karnataka, India.
  • Kumar S; Jubilant Biosys Limited, #96, Industrial Suburb 2nd Stage, Yeshwanthpur, Bengaluru 560022, Karnataka, India.
  • Nagaraju S; Jubilant Biosys Limited, #96, Industrial Suburb 2nd Stage, Yeshwanthpur, Bengaluru 560022, Karnataka, India.
  • Jegatheesan SK; Jubilant Biosys Limited, #96, Industrial Suburb 2nd Stage, Yeshwanthpur, Bengaluru 560022, Karnataka, India.
Drug Discov Today ; 23(7): 1444-1451, 2018 07.
Article in En | MEDLINE | ID: mdl-29753878
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Design / Basic Helix-Loop-Helix Transcription Factors / Molecular Targeted Therapy / Neoplasms / Antineoplastic Agents Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Drug Discov Today Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2018 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Design / Basic Helix-Loop-Helix Transcription Factors / Molecular Targeted Therapy / Neoplasms / Antineoplastic Agents Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Drug Discov Today Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2018 Document type: Article